Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

Affiliations

• ¹ Department of Microbiology, Immunology, and Inflammation, Center for NeuroVirology and Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA. [email protected].
• ² Department of Microbiology, Immunology, and Inflammation, Center for NeuroVirology and Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA.
• ³ Excision BioTherapeutics, Inc., San Francisco, CA, USA.
• ⁴ Center for Biostatistics and Epidemiology, Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA.
• ⁵ BioQual, Inc., Rockville, MD, USA.
• ⁶ Embleema, Metuchen, NJ, USA.
• ⁷ Excision BioTherapeutics, Inc., San Francisco, CA, USA. [email protected].
• ⁸ Department of Microbiology, Immunology, and Inflammation, Center for NeuroVirology and Gene Editing, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, 19140, USA. [email protected].